Pharmacokinetics (PK) and Safety of Multiple Doses of Intranasal Naloxone in Healthy Adults
Condition: Opioid Overdose Interventions: Combination Product: 16 mg naloxone AP003; Combination Product: 8 mg naloxone NARCAN Nasal Spray Sponsor: Emergent BioSolutions Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 17, 2022 Category: Research Source Type: clinical trials